On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its T-SPOT.TB test and associated accessories to the Stop TB Partnership – Global Drug Facility (GDF). This followed the inclusion of the T-SPOT.TB test in the GDF’s diagnostics catalog for the detection of tuberculosis (TB) infection